Ophirex Appoints Jeremy Gowler as CEO

Corte Madera, CA, July 15, 2024 (Business Wire) -- Ophirex, Inc., a company focused on developing an oral treatment for snakebite victims, has appointed Jeremy Gowler as CEO. Prior to joining Ophirex, Gowler was the interim CEO of Invivyd, and previously held positions at Sandoz, Emergent BioSolutions and Novartis.

Read full article here.